COH Share Price Performance
AU$0
-265.76 (-100.00%)
Price AU$0
Fair ValueAU$250.59
Share Pricen/a
Cochlear Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 63 Fair Values set on narratives written by author
COH Community Narratives
AN
Fair Value AU$250.59 26.8% undervalued intrinsic discount
Aging Population Will Spur Cochlear Implant Adoption Worldwide
1users have liked this narrative
0users have commented on this narrative
34users have followed this narrative
AN
Fair Value AU$210 12.7% undervalued intrinsic discount
Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value AU$350 47.6% undervalued intrinsic discount
Hearing Health Tailwinds And Cloud Capabilities Will Support Multi Year Earnings Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Aging Population Will Spur Cochlear Implant Adoption Worldwide
Key Takeaways Market leadership is reinforced by innovative products, premium pricing, and ongoing R&D, ensuring product differentiation and sustainable margins in both developed and emerging markets. Demographic trends and greater awareness of hearing loss are expanding the addressable market, driving long-term growth through increased interventions and recurring revenue from upgrades and services.Read more
208
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
34users have followed this narrative
AN
AU$250.59
26.8% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
9.12% p.a.
Profit Margin
18.35%
Future PE
36.35x
Price in 2029
AU$309.65
Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability
Catalysts About Cochlear Cochlear develops and manufactures hearing implant systems for people with severe to profound hearing loss. What are the underlying business or industry changes driving this perspective?Read more
44
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AU$210
12.7% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
7.45% p.a.
Profit Margin
18.3%
Future PE
32.2x
Price in 2029
AU$261.18
Hearing Health Tailwinds And Cloud Capabilities Will Support Multi Year Earnings Expansion
Catalysts About Cochlear Cochlear develops and manufactures implantable hearing solutions for people with severe to profound hearing loss. What are the underlying business or industry changes driving this perspective?Read more
54
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AU$350
47.6% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
14.36% p.a.
Profit Margin
20.5%
Future PE
39.58x
Price in 2029
AU$435.04
Trending Discussion
Recently Updated Narratives
AN
COH: Steady Assumptions And New Access Channels Will Support Future Upside Potential
Fair Value: AU$250.59 26.8% undervalued intrinsic discount
34 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability
Fair Value: AU$210 12.7% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Hearing Health Tailwinds And Cloud Capabilities Will Support Multi Year Earnings Expansion
Fair Value: AU$350 47.6% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Cochlear Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 18, 2026
- 5.28
- 72.76%
- 14.77%
- 0.7%
About COH
- Founded
- 1981
- Employees
- 5500
- CEO
- WebsiteView website
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
